1492 Capital Management’s Encompass Health EHC Stock Holding History

1492 Capital Management’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-58,112	Closed	-$5.89M	–	120
2025 Q1	$5.89M	Sell	58,112 -403	-0.7%	-$39.3K	3.17%	4
2024 Q4	$5.4M	Sell	58,515 -575	-1%	-$56.5K	2.57%	10
2024 Q3	$5.71M	Sell	59,090 -638	-1%	-$57.3K	2.85%	7
2024 Q2	$5.12M	Buy	59,728 +40	+0.1%	+$3.36K	2.9%	6
2024 Q1	$4.93M	Buy	59,688 +28,063	+89%	+$2.06M	2.74%	9
2023 Q4	$2.11M	Sell	31,625 -232	-0.7%	-$15K	1.2%	28
2023 Q3	$2.14M	Sell	31,857 -787	-2%	-$54.1K	1.38%	28
2023 Q2	$2.21M	Sell	32,644 -32	-0.1%	-$2K	1.29%	28
2023 Q1	$1.77M	Buy	32,676 +3,526	+12%	+$205K	1.09%	31
2022 Q4	$1.74M	Sell	29,150 -786	-3%	-$42.7K	1.12%	30
2022 Q3	$1.35M	Buy	29,936 +24,988	+505%	+$1.25M	0.97%	35
2022 Q2	$221K	Buy	+4,948	New	+$254K	0.15%	96
2020 Q3	–	Sell	-19,622	Closed	-$967K	–	97
2020 Q2	$967K	Buy	+19,622	New	+$1.06M	0.83%	36

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

1492 Capital Management's EHC Position: Q2 2025 in Review

1492 Capital Management sold out of Encompass Health (EHC) in Q2 2025, closing a stake of 58,112 shares — an estimated $5.89M sold.

1492 Capital Management first reported a position in EHC in Q2 2020 and held it in 13 quarters. The position peaked at $5.89M in Q1 2025. 607 funds tracked by Wall St. Rank hold EHC as of Q2 2025.

1492 Capital Management reported no remaining Encompass Health position as of Q2 2025 after selling out during the quarter.
1492 Capital Management sold 58,112 Encompass Health shares in Q2 2025, an estimated $5.89M.
1492 Capital Management first reported a position in Encompass Health in Q2 2020 and held it in 13 quarters.
1492 Capital Management's Encompass Health position peaked at $5.89M in Q1 2025.
607 funds tracked by Wall St. Rank held Encompass Health as of Q2 2025.

Based on 1492 Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.